From genes to survival: A novel cholesterol-based risk model for osteosarcoma

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Radiation Research and Applied Sciences

• Publication date

  2025-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jrras.2025.102042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and Validation of a Cholesterol-related Gene Signature for Prognostic Assessment in Head and Neck Squamous Cell Carcinoma.

  2024cited by this paper
• FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer

  2024cited by this paper
• Regulation of lipid metabolism by APOE4 in intrahepatic cholangiocarcinoma via the enhancement of ABCA1 membrane expression

  2024cited by this paper
• Lipid unsaturation promotes BAX and BAK pore activity during apoptosis

  2024cited by this paper
• Analysis of transcriptomic data reveals the landscape of cholesterol metabolism in prostate cancer and impact of related signature on survival

  2024cited by this paper
• Indirect bilirubin impairs invasion of osteosarcoma cells via inhibiting the PI3K/AKT/MMP-2 signaling pathway by suppressing intracellular ROS

  2023cited by this paper
• Targeting proteostasis network in osteoporosis: pathological mechanisms and therapeutic implications.

  2023cited by this paper
• Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC

  2023cited by this paper
• Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family

  2023cited by this paper
• Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration

  2023cited by this paper
• Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models

  2023cited by this paper
• Emerging roles and mechanisms of semaphorins activity in cancer.

  2023cited by this paper
• Construction and validation of a novel NAD+ metabolism‐related risk model for prognostic prediction in osteosarcoma

  2023cited by this paper
• FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer.

  2023cited by this paper
• Osteosarcoma

  2022cited by this paper
• Determination of Breast Metabolic Phenotypes and Their Associations With Immunotherapy and Drug-Targeted Therapy: Analysis of Single-Cell and Bulk Sequences

  2022cited by this paper
• Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases

  2022cited by this paper
• SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

  2021cited by this paper
• ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3

  2021cited by this paper
• Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer

  2021cited by this paper
• Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

  2021cited by this paper
• Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer

  2021cited by this paper
• Preoperative prognostic nutritional index and systemic immune‐inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients

  2021cited by this paper
• Metabolic reprogramming and cancer progression

  2020cited by this paper
• Annexin A13 predicts poor prognosis for lung adenocarcinoma patients and accelerates the proliferation and migration of lung adenocarcinoma cells by modulating epithelial–mesenchymal transition

  2020cited by this paper
• Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma

  2020cited by this paper
• Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma

  2019cited by this paper
• Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity

  2019cited by this paper
• MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression

  2019cited by this paper
• Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.

  2019cited by this paper
• Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.

  2019cited by this paper
• Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

  2018cited by this paper
• Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells*

  2016cited by this paper
• Metabolic control of epigenetics in cancer

  2016cited by this paper
• Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis

  2009cited by this paper

• No citing papers are available for this paper.